Ads
related to: largest independent pharmacy chains in california by zip code lookup 4
Search results
Results From The WOW.Com Content Network
The average independent pharmacy had total sales of approximately $4 million and average prescription sales of approximately $3.7 million per location (accounting for 92.5% of all independent pharmacy sales). Over 26% of independent pharmacy owners have ownership in two or more pharmacies. [2]
The remaining pharmacies are considered to be independent or privately owned. The top 25 pharmacy chain stores represent about 38,000 pharmacy locations in the U.S. and employ about 149,000 on-staff pharmacists. California has 8,015 pharmacies, the most of any state.
In 2011, Health Mart topped traditional chain drug stores in terms of pharmacy customer satisfaction in a JD Power study. [3] In 2013, Health Mart was recognized by Drug Store News as the nation's largest independent pharmacy franchise and one of the fastest growing drug store networks of any kind with more than 3,100 member stores. [4]
Many pharmacy chains in the United States are owned and operated by regional supermarket brands, or national big-box store brands such as Walmart. These pharmacies are located within their larger chain stores. The three largest free-standing pharmacy chains in the United States are Walgreens, CVS, and Rite Aid.
CVS, the largest US chain, closed 244 stores between 2018 and 2020. In 2021, it announced plans to close 900 stores. And Rite Aid filed for bankruptcy last year and will close up to 500 stores.
Between 2022 and 2023, so far, 99 new independent pharmacies have opened, which translates to 0.4% growth, according to the Pharmaceutical Care Management Association.
Cigna's Express Scripts has previously said that, as of 2022, 35% of its pharmacy network was independent pharmacies, while retail chains accounted for 33% and grocery chains were 32% ...
In 2020, Massachusetts CVS stores lost controlled substances at a rate several times higher than other pharmacy chains. [94] CVS was fined $5 million by the federal government in 2017 for controlled substance losses and other violations in California pharmacies, and $1.5 million in 2018 for failing to report losses from New York pharmacies. [94]